The objective of this study was to analyze the roles of demographic, clinical, and laboratory factors on the progression of atherosclerotic stenosis in carotid bifurcation. It was based on prospective information from records entered on a specific application form for follow-up outpatients at a tertiary university service.
Methods
Consecutive symptomatic and asymptomatic patients (n = 210) who had undergone more than one carotid duplex scan but no surgical intervention were selected for the analysis. The patients were divided into two groups: patients whose duplex scans did not show bilateral progression of carotid stenosis and patients with carotid stenosis progression of <50%, 50%–69%, or >70%. Clinical and demographic parameters were compared between groups.
Results
Group II levels of plasma urea (51.6 ± 27.8 mg/dl) and fibrinogen (493.2 ± 113.3 mg/dl) were higher than the Group I levels (43.0 ± 14.9 mg/dl and 441.3 ± 106.7 mg/dl, respectively) with statistical significance (p urea = 0.013 and p fibrinogen = 0.018). Paradoxically, the mean body mass index was higher in Group I (26.4 ± 4.6 kg/m2) than in Group II (24.6 ± 3.9 kg/m2; p = 0.02).
Conclusions
Traditional risk factors for the development of atherosclerosis in a carotid bifurcation are important but not unique. Metabolic and inflammatory factors can contribute to disease progression.
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA1995; 273: 1421–1428.
2.
HallidayAHarrisonMHayterE. Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet2010; 376: 1074–1084.
3.
de WeerdMGrevingJPHedbladB. Prediction of asymptomatic carotid artery stenosis in the general population: identification of high-risk groups. Stroke2014; 45: 2366–2371.
4.
MathiesenEBJoakimsenOBønaaKH. Prevalence of and risk factors associated with carotid artery stenosis: the Tromsø Study. Cerebrovasc Dis2001; 12: 44–51.
5.
MartinDZamanAHackerJ. Analysis of haemodynamic factors involved in carotid atherosclerosis using computational fluid dynamics. Br J Radiol2009; 82: S33–S38.
6.
LeeSWAntigaLSpenceJD. Geometry of the carotid bifurcation predicts its exposure to disturbed flow. Stroke2008; 39: 2341–2347.
7.
GrantEGBensonCBMonetaGL. Carotid artery stenosis: gray-scale and Doppler US diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology2003; 229: 340–346.
8.
GrundySMCleemanJIDanielsSR. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol2005; 4: 198–203.
9.
Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet2005; 366: 1059–1062.
10.
Jerrard-DunnePMarkusHSSteckelDA. Early carotid atherosclerosis and family history of vascular disease: specific effects on arterial sites have implications for genetic studies. Arterioscler Thromb Vasc Biol2003; 23: 302–306.
11.
HirschATHaskalZJHertzerNR. Circulation2006; 113: e463–e654. American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 2006; 113: e463--e654.
12.
LijmerJGHuninkMGvan den DungenJJ. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol1996; 22: 391–398.
13.
TimaranCHMcKinseyJFSchneiderPA. Reporting standards for carotid interventions from the Society for Vascular Surgery. J Vasc Surg2011; 53: 1679–1695.
14.
DuaAPatelBKuyS. Asymptomatic 50% to 75% internal carotid artery stenosis in 288 patients: risk factors for disease progression and ipsilateral neurological symptoms. Perspect Vasc Surg Endovasc Ther2012; 24: 165–170.
15.
OharaTKokuboYToyodaK. Impact of chronic kidney disease on carotid atherosclerosis according to blood pressure category: the Suita study. Stroke2013; 44: 3537–3539.
16.
YangPYuanHWengC. Carotid intima-media thickness and estimated glomerular filtration rate in hypertensive patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban2014; 39: 465–470.
17.
KokuboY. Carotid atherosclerosis in kidney disease. Contrib Nephrol2013; 179: 35–41.
18.
FabrisFZanocchiMBoM. Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke1994; 25: 1133–1140.
19.
MullenixPSSteeleSRMartinMJ. C-reactive protein level and traditional vascular risk factors in the prediction of carotid stenosis. Arch Surg2007; 142: 1066–1071.
20.
LombardoABiasucciLMLanzaGA. Inflammation as a possible link between coronary and carotid plaque instability. Circulation2004; 109: 3158–3163.
21.
HackamDGAnandSS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA2003; 290: 932–940.
22.
LarssonPTHallerstamSRosforsS. Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol2005; 24: 43–51.
23.
DavenportDLXenosESHosokawaP. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg2009; 49: 140–147.
24.
TeulJRupérezFJGarciaA. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints. J Proteome Res2009; 8: 5580–5589.
25.
Martinez-PinnaRBarbasCBlanco-ColioLM. Proteomic and metabolomic profiles in atherothrombotic vascular disease. Curr Atheroscler Rep2010; 12: 202–208.
26.
van KuijkJPFluWJGalalW. The influence of polyvascular disease on the obesity paradox in vascular surgery patients. J Vasc Surg2011; 53: 399–406.
27.
JacksonRSBlackJH3rdLumYW. Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy. J Vasc Surg2012; 55: 1306–1312.
